Your description
Employees: 201-500
Mentions in press and media 14
| Date | Title | Description |
| 20.12.2024 | Singapore’s Eureka Robotics raised $10.5 M Series A funding from B Capital | Singapore-based startup in robotics A global multi-stage investment firm called B Capital is leading Eureka Robotics’ $10.5 million Series A funding round. New investors Airbus Ventures, an independent venture capital firm serving deep tech... |
| 14.12.2024 | Eureka Robotics: Pioneering Precision in Manufacturing with New Funding | Eureka Robotics is on the rise. The Singapore-based company has just secured USD 10.5 million in Series A funding. This financial boost is not just a number; it’s a ticket to the future of robotics and AI in manufacturing. Led by B Capital,... |
| 13.12.2024 | Eureka Robotics: $10.5 Million (Series A) Raised To Help Factories Automate Work | Singapore-based Eureka Robotics has announced it has raised a $10.5 million Series A round led by B Capital. New investors Airbus Ventures, Maruka Corporation, and G. K. Goh Ventures participated, as did returning investors UTEC and ATEQ. T... |
| 12.12.2024 | Eureka Robotics Raises USD 10.5 Million Series A to Accelerate Deployment of Physical AI for Precision Manufacturing and Logistics | Advances the development and deployment of flagship products Eureka Controller and Eureka 3D Camera Scales operations in Singapore and Japan, and enables full entry in the US market SINGAPORE, Dec. 12, 2024 /PRNewswire/ -- Singapore-based s... |
| 12.12.2024 | Eureka Robotics Raises USD 10.5M in Series A Funding | Eureka Robotics Co-Founders, Dr. Pham Quang Cuong (left) and Dr. Hung Pham Eureka Robotics, a Singapore-based robotics and AI research company, raised USD 10.5M in Series A funding. The round was led by B Capital, with participation from ne... |
| 22.10.2024 | Nuclera: Biotech Company Raises $75 Million For Accelerating Protein Expression | Nuclera, the biotechnology company accelerating protein expression and purification workflows through its benchtop protein system, announced it had completed a $75 million financing round (circa £57 million). The funding round was led by El... |
| 17.10.2024 | Nuclera's $75 Million Leap: A New Era for Protein Discovery | In the world of biotechnology, speed is everything. Nuclera, a Cambridge-based biotech company, has just secured a $75 million Series C funding round. This significant investment is a game-changer, pushing the boundaries of protein discover... |
| 16.10.2024 | Nuclera raises $75M Series C for eProtein discovery system | Biotech Nuclera has raised a $75 million Series C financing round. This brings the company’s funding to over $140 million. The company is accelerating protein expression and purification workflows through its benchtop protein system, eProte... |
| 03.02.2022 | Nuclera raises $42.5M in first close of Series B for desktop protein printer | Nuclera raises $42.5M in first close of Series B for desktop protein printer 03-02-2022 Nuclera, a biotech company developing cutting-edge benchtop protein printing technologies, announces that the first close of its Series B financing has ... |
| 03.02.2022 | Nuclera raises $42.5M in first close of Series B for desktop protein printer | Nuclera, a biotech company developing cutting-edge benchtop protein printing technologies, announces that the first close of its Series B financing has raised $42.5 million. The funds raised will be used to accelerate the development and co... |
Show more